Michael Bloch
Partner
London
Michael Bloch
Partner
London
Contact Details
Michael has extensive experience in a wide range of corporate finance and equity capital markets transactions, including IPOs, public and private acquisitions and disposals and auction processes, and private equity transactions, frequently on a cross-border basis.
Michael has also spent seven months on secondment in the ECM business team at Credit Suisse, and has previously worked on secondment at ExxonMobil.
“Rising Star” IFLR1000 2019 (Equity Capital Markets)
“‘Very technically savvy,’ ‘easy to work with’ and ‘a good, safe pair of hands.’” Chambers UK 2020 (Equity Capital Markets)
"He is really impressive" Chambers UK 2021 (Capital Markets: Equity)
"He has good experience and he's a nice guy to deal with" Chambers UK 2021 (Capital Markets: Equity)
"Next Generation Partner" Legall 500 UK 2021 (Equity Capital Markets - Mid-High Cap)
Other noteworthy experience includes advising:
- Kuwait Energy on its USD650m acquisition by United Energy Group by way of scheme of arrangement.
- McCarthy & Stone on its GBP388m IPO on the premium main market of the London Stock Exchange (issuer's counsel)
- Tullet Prebon on its reverse takeover acquisition of the global hybrid voice-broking and information business of ICAP plc.
- Cobham on its GBP500m and GBP512m rights issues on the London Stock Exchange (issuer's counsel)
- Equinity on its GBP317m IPO on the premium main market of the London Stock Exchange (underwriters counsel)
- Circassia Pharmaceuticals ont its GBP580m IPO on the premium main market of the London Stock Exchange and GBP275m placing and open offer in connection with the acquisitions of Aerocrine and Prosonix (issuer's counsel).
- Softcat on its GBP153m IPO on the premium main market of the London Stock Exchange (underwriter's counsel)
- Spire Healthcare on its GBP842m IPO on the premium main market of the London Stock Exchange (underwriter's counsel)
- Sensyne Health a digital healthcare company that develops regulated medical products and services using artificial intelligence, on its GBP225m IPO on the London Stock Exchange's AIM market.
- Medopad on its Series A funding round to develop its healthcare technology data-capture platform.
Expertise
Practices
Sectors
Qualifications
Professional
Academic
MA (Oxon), History, University of Oxford, 2002
Dip. Law, Nottingham Law School, 2003
LPC, Nottingham Law School, 2004
Related articles
Publications: 12 January 2022
What is driving record levels of fundraising by technology companies?
Technology and life sciences companies overwhelmingly dominated fundraising markets in 2021, beating all previous records for amounts raised.
Publications: 06 December 2021
FCA reforms UK listing regime to seek to attract dual-class share structures to London
Expertise
Practices
Sectors
Qualifications
Professional
Academic
MA (Oxon), History, University of Oxford, 2002
Dip. Law, Nottingham Law School, 2003
LPC, Nottingham Law School, 2004
Experience highlights
Advising DWF, this first premium listed law firm, on its GBP366m IPO on the premium main market of the London Stock Exchange (issuer's counsel).
Advising Marks & Spencer on its GBP750m joint venture with Ocado and associated GBP600m rights issue on the London Stock Exchange (issuer's counsel).
Advising Quilter (formally called Old Mutual Wealth) on its demerger from the Old Mutual group of companies and associated GBP2.8bn IPO on the premium main market of the London Stock Exchange and on the Johannesburg Stock Exchange (issuer's counsel)
Advising Sirius Minerals on its GBP370m firm placing and placing and open offer as part of its USD1.1bn stage 1 financing, subsequent listing on the premium main market of the London Stock Exchange, and GBP327m firm placing and open offer as part of its proposed USD3.8bn stage 2 financing (issuer's counsel).
Recognition
Rising star
IFLR1000
A strong technical and commercial ECM practitioner
Legal 500 UK 2019
Very technically savvy" "easy to work with" and "a good, safe pair of hands
Legal 500 UK 2019
